CNR Institutional Research Information System

CAPUTO, EMILIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.213
NA - Nord America 868
EU - Europa 297
SA - Sud America 192
Continente sconosciuto - Info sul continente non disponibili 43
AF - Africa 38
OC - Oceania 2
Totale 2.653
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 820
SG - Singapore 426
CN - Cina 310
BR - Brasile 149
HK - Hong Kong 130
IT - Italia 96
VN - Vietnam 93
KR - Corea 77
FR - Francia 74
BD - Bangladesh 53
JP - Giappone 35
NL - Olanda 28
IN - India 27
DE - Germania 22
CA - Canada 21
FI - Finlandia 19
ID - Indonesia 15
AR - Argentina 14
ZA - Sudafrica 12
GB - Regno Unito 11
EC - Ecuador 10
TR - Turchia 9
AT - Austria 8
IL - Israele 8
RU - Federazione Russa 8
MX - Messico 7
DZ - Algeria 6
CO - Colombia 5
CR - Costa Rica 5
KE - Kenya 5
MA - Marocco 5
PH - Filippine 5
SE - Svezia 5
VE - Venezuela 5
ES - Italia 4
PL - Polonia 4
PY - Paraguay 4
CH - Svizzera 3
CL - Cile 3
DO - Repubblica Dominicana 3
EG - Egitto 3
IQ - Iraq 3
PK - Pakistan 3
BE - Belgio 2
CD - Congo 2
CZ - Repubblica Ceca 2
GT - Guatemala 2
IE - Irlanda 2
JM - Giamaica 2
JO - Giordania 2
MY - Malesia 2
NP - Nepal 2
PE - Perù 2
SA - Arabia Saudita 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
YE - Yemen 2
AE - Emirati Arabi Uniti 1
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
AM - Armenia 1
AO - Angola 1
AU - Australia 1
BB - Barbados 1
BZ - Belize 1
CM - Camerun 1
DM - Dominica 1
EE - Estonia 1
GE - Georgia 1
HN - Honduras 1
LB - Libano 1
LU - Lussemburgo 1
LV - Lettonia 1
LY - Libia 1
MD - Moldavia 1
MU - Mauritius 1
NI - Nicaragua 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PA - Panama 1
PT - Portogallo 1
RO - Romania 1
SN - Senegal 1
SY - Repubblica araba siriana 1
UA - Ucraina 1
UZ - Uzbekistan 1
Totale 2.610
Salva come PNG Salva come JPEG
Città #
Singapore 256
Santa Clara 238
Hefei 165
Hong Kong 127
San Jose 81
Seoul 77
Ashburn 73
Beijing 53
Lauterbourg 45
Los Angeles 35
Ho Chi Minh City 31
Tokyo 26
New York 21
Hanoi 20
Dallas 19
Helsinki 15
Rio de Janeiro 14
Naples 12
Rome 11
Frankfurt am Main 10
Milan 10
São Paulo 10
Buffalo 9
Charlotte 9
Minamishinagawa 9
Council Bluffs 8
Montreal 8
Amsterdam 7
Bengaluru 7
Boardman 7
Houston 7
Brooklyn 6
Haiphong 6
Philadelphia 6
Düsseldorf 5
Guayaquil 5
Johannesburg 5
Orem 5
Stockholm 5
Vienna 5
Atlanta 4
Buenos Aires 4
Da Nang 4
Falkenstein 4
Figino 4
Jakarta 4
Lappeenranta 4
London 4
Nairobi 4
Paris 4
Ribeirão Preto 4
San José 4
Bandung 3
Belo Horizonte 3
Biên Hòa 3
Brasília 3
Cape Town 3
Casandrino 3
Curitiba 3
Denver 3
Fortaleza 3
Ha Long 3
Kingston 3
Manila 3
Nova Iguaçu 3
Passo Fundo 3
Rancho Cucamonga 3
Redondo Beach 3
Salvador 3
Verona 3
Warsaw 3
Winnipeg 3
Zurich 3
Amman 2
Antalya 2
Asunción 2
Bari 2
Beckley 2
Bogotá 2
Bologna 2
Bắc Ninh 2
Cachoeirinha 2
Cairo 2
Cajamar 2
Caldwell 2
Campinas 2
Canal Winchester 2
Cao Lanh 2
Casablanca 2
Chicago 2
Cleveland 2
Columbia 2
Cuenca 2
Dublin 2
Fort Erie 2
Guarulhos 2
Guatemala City 2
Hải Dương 2
Jeddah 2
Joinville 2
Totale 1.633
Salva come PNG Salva come JPEG
Nome #
Moving towards Biofuels and High-Value Products through Phytoremediation and Biocatalytic Processes 116
SARS-CoV-2: Searching for the missing variants 105
Structural study of GCDFP-15/gp17 in disease versus physiological conditions using a proteomic approach 105
Exploring New Fruit- and Vegetable-Derived Rennet for Cheese Making 97
Origin and main features of gryphon, cerberus, kraken, orthrus, bythos, hyperion and arctur, the current SARS-CoV-2 variants. 95
Brassicaceae-Derived Anticancer Agents: Towards a Green Approach to Beat Cancer 94
Structural and Phylogenetic Analysis of SARS-CoV-2 Spike Glycoprotein from the Most Widespread Variants 89
Chemical Composition, Functional and Anticancer Properties of Carrot 89
Phylogenetic Analysis of Omicron Variants and their Evolutionary Relationship with SARS-CoV-2 Spike Glycoprotein 86
SARS-COV-2 INFECTION: A CASE FAMILY REPORT 77
Different Extraction Procedures Revealed the Anti-Proliferation Activity from Vegetable Semi-Purified Sources on Breast Cancer Cell Lines 75
Phenotype characterization of human melanoma cells resistant to Dabrafenib 72
Breast Cancer Tissues and Organoids BioBank: Constitution, Research Activities and Samples Access 71
Phenotype Characterization of Human Melanoma Cells Resistant to Dabrafenib. 67
Melanoma Immunotherapy and Precision Medicine in the Era of Tumor Micro-Tissue Engineering: Where Are We Now and Where Are We Going? 62
The Aes protein and the monomeric alpha-galactosidase from Escherichia coli form a non-covalent complex. Implications for the regulation of carbohydrate metabolism 60
The miRNAs role in melanoma and in its resistance to therapy 58
SARS-COV-2 INFECTION IN ITALY: ITS PROGRESSION FROM FEBRUARY TO MAY 2020 57
Ran signaling in melanoma: Implications for the development of alternative therapeutic strategies. 55
Cheese making: new perspective in lipolysis and influence of exogenous enzymes in fatty acids and volatile compound profile of semi hard cheeses 53
AurkA inhibitors enhance the effects of B-RAF and MEK inhibitors in mela-noma treatment 52
Melanoma Drug Treatment 51
c-Myc Modulation: a Key Role in Melanoma Drug Response 49
AurkA inhibitors enhance the effects of B-RAF and MEK inhibitors in melanoma treatment 48
The Aes protein and the monomeric a-galactosidase from Escherichia coli form a non-covalent complex. Implications for the regulation of carbohydrate metabolism. 46
The Rhizobium etli argC gene is essential for Arginine biosynthesis and nodulation of Phaseolus vulgaris 46
Curcumin impacts on cisplatin sensitivity determining apoptotic boost in mesothelioma 46
The Rhizobium etli trpB gene is essential for an effective symbiotic interaction with Phaseolus vulgaris 46
Piroxicam and cisplatin combined treatment enhances apoptosis in mesothelioma cells via p21 nuclear shifting. 44
The Rhizobium etli metZ gene is essential for methionine biosynthesis and nodulation of Phaseolus vulgaris. 44
Gene Expression Profiling in Melanoma 44
A Look Inside of the Complex Pathogenesis of B-RAF(V600E)-Driven Cancer 44
Nrf2 as a Therapeutic Target in the Resistance to Targeted Therapies in Melanoma 42
Biosynthesis and immunobiochemical characterization of gp17/GCDFP-15. A glycoprotein from seminal vesicles and from breast tumors, in HeLa cells and in Pichia pastoris yeast. 40
Biomarker Discovery 34
A novel aspartyl-proteinase from apocrine epithelia and breast tumors. 34
Anti-proliferative and pro-apoptotic effect of ABT888 on melanoma cell lines and its potential role in the treatment of melanoma resistant to B-RAF inhibitors. 34
Characterization of human melanoma cell lines and melanocytes by proteome analysis 32
Differential antibody reactivity and CD4 binding of the mammary tumor marker protein GCDFP-15 from breast cyst and its counterparts from exocrine epithelia. 32
Assessment of antibody-antigen interaction using SELDI technology . 32
Caratterizzazione molecolare del melanoma mediante uno studio combinato di genomica e networks molecolari 30
Methods for on chip Protein Analysis 30
Human Melanoma Cells Resistant to B-RAF and MEK inhibition Exhibit Mesenchymal-like Features. 30
Analysis of CD4 and FN interaction with GCDFP-15/gp17 by ProteinChip Technology 30
Caratterizzazione di gp17, una proteina che si lega a CD4 28
Differential antibody reactivity and CD4 binding of the mammary tumor marker protein GCDFP-15 from breast cyst and its counterparts from exocrine epithelia. 27
Phenotype characterization of human melanoma cells resistant to dabrafenib 24
Peptide profiling in epithelial tumor plasma by the emerging proteomic techniques 20
Exploiting vegetarian and vegan cheeses with hibiscus extract: Functional and nutritional perspectives 11
Totale 2.653
Salva come PNG Salva come JPEG
Categoria #
all - tutte 8.530
article - articoli 6.689
book - libri 424
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 530
Totale 16.173
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202414 0 0 0 0 0 0 0 0 0 1 4 9
2024/2025831 10 3 56 22 164 63 4 72 28 42 215 152
2025/20261.502 112 165 131 195 257 49 198 63 87 94 109 42
2026/2027306 116 52 138 0 0 0 0 0 0 0 0 0
Totale 2.653